146 filings
Page 2 of 8
6-K
ep6cqnb0em5t76jtcgr
17 May 23
BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
7:30am
6-K
oxb7rpy9
20 Mar 23
Current report (foreign)
4:01pm
6-K
0a6xbv8
15 Mar 23
BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights
7:30am
6-K
ag6o 914uqz
13 Feb 23
Notice of Annual General Meeting of Shareholders
4:01pm
6-K
ynacun55r1w
13 Feb 23
BrainsWay Announces Appointment of Ami Boehm as New Chairman
7:30am
6-K
1x0 hpe6mcl8mitpigr
13 Feb 23
BrainsWay Announces Appointment of Hadar Levy as CEO
7:30am
6-K
6d17lf 6k
12 Jan 23
BrainsWay Appoints Ami Boehm as Board Member
8:01am
6-K
xipj49
10 Jan 23
Current report (foreign)
8:00am
6-K
jmaqvdos4f1cnmusw1
28 Nov 22
BrainsWay Reports Open Market Stock Purchases by Two Board Members
7:31am
6-K
hs26kyoo7 jov
16 Nov 22
BrainsWay Reports Third Quarter 2022 Financial Results and Operational Highlights
7:30am
6-K
34e8yuno
14 Sep 22
Current report (foreign)
7:30am
6-K
h25ecf671jlkg
29 Aug 22
BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression
8:00am
6-K
elvor7q
10 Aug 22
BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights
7:30am
6-K
squy2dpjjr2kxtv0om
28 Jun 22
BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression
8:00am
6-K
fhxzt18jvs xxj4
11 May 22
BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights
7:30am
6-K
5e8ihctfrv720
9 Mar 22
BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights
7:30am
6-K
7uyqulhd7jsgsk yfn0z
31 Jan 22
Current report (foreign)
7:30am
6-K
qrhl3i79qiqhiv1wf
23 Dec 21
Current report (foreign)
8:00am